Filed before 2025Filed 21 November 2018
Progentec Diagnostics, Inc. has sold $2.5M so far
Progentec Diagnostics, Inc., a biotech company based in Oklahoma City, OK, has sold $2.5M so far in its convertible round, according to a filing dated 21 November 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 November 2018
- Round
- Convertible round (amended filing)
- Amount sold
- $2.5M
- Offering size
- $2.5M
- Investors so far
- 7
- Based in
- Oklahoma City, OK
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 27% of the 1,729 tracked raises with an amount filed in 2018, and than 23% of the 160 in biotech.
Progentec Diagnostics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 21 Nov 2018 | Amended filing | $2.5M | This raise |
More with OCA Ventures on the board
- Ocient Inc.Undisclosed
- DesiCorp, Inc.$3.5M
- Amplified Sciences, Inc.$2.99M
- Prisidio Inc.$14.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.